Literature DB >> 3290019

Absence of glucopenic inhibition of the insulin response to arginine at the onset of diabetes in BB/W rats.

I Komiya1, R H Unger.   

Abstract

To determine if the inhibiting effect of glucopenia on arginine-stimulated insulin secretion is impaired at the onset of autoimmune diabetes, the insulin response to arginine was studied at 5.6 and 2.8 mmol/l glucose in perfused pancreata isolated from BB/W rats on the first day of diabetes and from age-matched diabetes-prone BB/W rats without diabetes. During glucopenia the baseline insulin secretion was reduced by more than 80% in both groups. However, the arginine-stimulated insulin response in the diabetic group was only 16.5% lower during glucopenia compared to 79.1% lower in the nondiabetic controls. Also, enhancement of the arginine-stimulated glucagon response by glucopenia was modest compared to controls. The results indicated that at the onset of this form of autoimmune diabetes the surviving B cells are, for unknown reasons, hyperresponsive to arginine and that, in contrast to the controls, this response is not inhibited by glucopenia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290019     DOI: 10.1007/bf00290589

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  The in vitro perfused pancreas.

Authors:  G M Grodsky; R E Fanska
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Immunoassay of endogenous plasma insulin in man.

Authors:  R S YALOW; S A BERSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

3.  Quantitative study on the potentiating effect of arginine on glucose-induced insulin response in healthy, prediabetic, and diabetic subjects.

Authors:  S Efendić; E Cerasi; R Luft
Journal:  Diabetes       Date:  1974-03       Impact factor: 9.461

4.  Synergistic effect of essential amino acids and glucose upon insulin secretion in man.

Authors:  J C Floyd; S S Fajans; S Pek; C A Thiffault; R F Knopf; J W Conn
Journal:  Diabetes       Date:  1970-02       Impact factor: 9.461

5.  Coated charcoal immunoassay of insulin.

Authors:  V Herbert; K S Lau; C W Gottlieb; S J Bleicher
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

6.  Adrenergically mediated intrapancreatic control of the glucagon response to glucopenia in the isolated rat pancreas.

Authors:  A Hisatomi; H Maruyama; L Orci; M Vasko; R H Unger
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

7.  Growth hormone and insulin release after arginine: indifference to hyperglycemia and epinephrine.

Authors:  D Rabinowitz; T J Merimee; J A Burgess; L Riggs
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

8.  Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

Authors:  J P Palmer; J W Benson; R M Walter; J W Ensinck
Journal:  J Clin Invest       Date:  1976-09       Impact factor: 14.808

9.  Morphologic and functional changes in sympathetic nerve relationships with pancreatic alpha-cells after destruction of beta-cells in rats.

Authors:  M Tominaga; H Maruyama; M R Vasko; D Baetens; L Orci; R H Unger
Journal:  Diabetes       Date:  1987-03       Impact factor: 9.461

10.  Loss of insulin response to glucose but not arginine during the development of autoimmune diabetes in BB/W rats: relationships to islet volume and glucose transport rate.

Authors:  M Tominaga; I Komiya; J H Johnson; L Inman; T Alam; J Moltz; B Crider; Y Stefan; D Baetens; K McCorkle
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.